Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
  • A61K31/47—Quinolines; Isoquinolines
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
  • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
  • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P11/00—Drugs for disorders of the respiratory system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P13/00—Drugs for disorders of the urinary system
  • A61P13/08—Drugs for disorders of the urinary system of the prostate
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P13/00—Drugs for disorders of the urinary system
  • A61P13/12—Drugs for disorders of the urinary system of the kidneys
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P17/00—Drugs for dermatological disorders
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
  • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
  • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
  • C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4

Applications Claiming Priority (1)

Publications (1)

Family

ID=57585165

Family Applications (2)

Family Applications Before (1)

Country Status (21)

Families Citing this family (5)

Family Cites Families (14)

• 2016
  • 2016-06-24 US US15/574,060 patent/US10449189B2/en active Active
  • 2016-06-24 ES ES16814513T patent/ES2928684T3/en active Active
  • 2016-06-24 DK DK16814513.4T patent/DK3315131T3/en active
  • 2016-06-24 CN CN202110067291.6A patent/CN112716952A/en active Pending
  • 2016-06-24 RU RU2017145271A patent/RU2729630C2/en active
  • 2016-06-24 EP EP21205221.1A patent/EP3973962A1/en active Pending
  • 2016-06-24 SG SG11201709260TA patent/SG11201709260TA/en unknown
  • 2016-06-24 CN CN201680037175.7A patent/CN107708697B/en active Active
  • 2016-06-24 WO PCT/JP2016/068902 patent/WO2016208744A1/en active Application Filing
  • 2016-06-24 PT PT168145134T patent/PT3315131T/en unknown
  • 2016-06-24 MY MYPI2017704204A patent/MY191219A/en unknown
  • 2016-06-24 BR BR112017028137-6A patent/BR112017028137B1/en active IP Right Grant
  • 2016-06-24 AU AU2016284531A patent/AU2016284531B2/en active Active
  • 2016-06-24 MA MA042266A patent/MA42266A/en unknown
  • 2016-06-24 HU HUE16814513A patent/HUE060732T2/en unknown
  • 2016-06-24 SG SG10201912684TA patent/SG10201912684TA/en unknown
  • 2016-06-24 MX MX2017016774A patent/MX2017016774A/en unknown
  • 2016-06-24 JP JP2017525457A patent/JP6974167B2/en active Active
  • 2016-06-24 PL PL16814513.4T patent/PL3315131T3/en unknown
  • 2016-06-24 CA CA2990791A patent/CA2990791A1/en active Pending
  • 2016-06-24 KR KR1020177033481A patent/KR102647942B1/en active IP Right Grant
  • 2016-06-24 EP EP16814513.4A patent/EP3315131B1/en active Active
• 2017
  • 2017-12-15 PH PH12017502322A patent/PH12017502322A1/en unknown
  • 2017-12-19 MX MX2020012989A patent/MX2020012989A/en unknown
• 2018
  • 2018-04-18 HK HK18105026.7A patent/HK1245639A1/en unknown
• 2019
  • 2019-09-17 US US16/573,362 patent/US10695340B2/en active Active
• 2020
  • 2020-06-02 US US16/889,870 patent/US11191759B2/en active Active
• 2021
  • 2021-10-29 US US17/513,946 patent/US11690838B2/en active Active
  • 2021-11-04 JP JP2021180108A patent/JP7258985B2/en active Active
• 2023
  • 2023-04-05 JP JP2023061284A patent/JP2023076632A/en active Pending

Also Published As

Similar Documents